H. Jeffrey Wilkins
Overview
H. Jeffrey Wilkins received an average of $1M in total compensation, including $380K in salary, at Avalo Therapeutics between 2020 and 2021.
Source: SEC filing on April 25, 2022.
Related executives
We found 16 more executives who work or worked at Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
Simon Pedder
Avalo Therapeutics
Chairman
Pericles Calias
Avalo Therapeutics
Chief Scientific Officer
Joseph Miller
Avalo Therapeutics